TC BioPharm (Holdings) plc Quarterly Nonoperating Income (Expense) in GBP from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: GBP
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TC BioPharm (Holdings) plc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q1 2024.
  • TC BioPharm (Holdings) plc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was £9.06K, a 99.7% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2023 was £7.24M, a 20% decline from 2022.
Nonoperating Income (Expense), Quarterly (GBP)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 9.06K* -3.12M -99.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 3.13M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.